Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Physiomics Share News (PYC)
PYC Share
Price
PYC Share
News
PYC Share
Chat2
PYC Share
Trades3
PYC
Live RNS
PYC Share
Charts
PYC Level 2
Console
PYC Live
Share Price
PYC Broker
Ratings
PYC Directors
Deals
PYC Financial
Diary
PYC
Fundamentals
PYC Short
Positions
PYC
Media
PYC Company
Research
PYC Company
Timeline
Share Price Information for Physiomics (PYC)
Last checked at -
Last checked at 
Intraday Physiomics Share Chart
LONDON (Alliance News) - Physiomics PLC Monday said it has signed a contract with a new speciality pharmaceuticals customer to investigate how one of the client's new candidate drugs shrinks tumours.
Physiomics scientists will use systems biology approaches to map the possible pathways by which the drug could act, it said in a statement without giving any financial details. The analysis will be used to narrow down possible mechanisms and suggest new experiments that the client can perform to home in on one mechanism.
"If successful, the directors hope that Physiomics will be able to offer its other modelling services to this new client as the project progresses," the company said in a statement.
Physiomics shares were up 31.6% at 0.25 pence early Monday, the biggest gainer on AIM.
By Steve McGrath; stevemcgrath@alliancenews.com; @SteveMcGrath1
Copyright 2013 Alliance News Limited. All Rights Reserved.
Latest PYC News
- Physiomics reports higher interim revenue; loss narrows
7 Mar 2024 - Physiomics revenue rises, losses narrow in first half
7 Mar 2024 - UK earnings, trading statements calendar - next 7 days
4 Mar 2024 - Physiomics celebrates contract award for cancer therapy insect model
19 Feb 2024 - Physiomics secures contract with University of Sheffield
19 Feb 2024 - IN BRIEF: Physiomics wins deal to support client's oncology assets
5 Feb 2024 - Physiomics awarded further contract by Numab Therapeutics
5 Feb 2024 - Physiomics appoints COO Sargent as new CEO; completes restructuring
22 Jan 2024
Related News
EXECUTIVE CHANGES: AB Dynamics appoints CFO; Physiomics names new COO
(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Wednesday and not separately reported...
Physiomics reports strong operational progress
(Sharecast News) - Physiomics said on Friday that it was making strong operational progress and building the largest commercial pipeline in its histor...
Physiomics reports strong operational progress
(Sharecast News) - Physiomics said on Friday that it was making strong operational progress and building the largest commercial pipeline in its histor...
Physiomics News
Physiomics reports higher interim revenue; loss narrows
(Alliance News) - Physiomics PLC on Thursday reported higher interim revenue and a narrowed loss.
Physiomics revenue rises, losses narrow in first half
(Sharecast News) - Physiomics reported revenue of £0.37m in its interim results on Thursday, up from the £0.34m it recorded a ...
Physiomics celebrates contract award for cancer therapy insect model
(Alliance News) - Physiomics PLC on Monday said that it has been awarded a contract by the University of Sheffield to support a grant-funded project f...
Physiomics secures contract with University of Sheffield
(Sharecast News) - Data science firm Physiomics has been chosen by the University of Sheffield to support a grant-funded project focused on an insect ...
IN BRIEF: Physiomics wins deal to support client's oncology assets
Physiomics PLC - mathematical modelling company that supports oncology drug development - Wins further contract from existing client Numab Therapeutic...
Physiomics awarded further contract by Numab Therapeutics
(Sharecast News) - Data science company Physiomics said on Monday that it had been awarded a further contract by an existing client.
Physiomics appoints COO Sargent as new CEO; completes restructuring
(Alliance News) - Physiomics PLC shares fell on Monday, after it named Chief Operating Officer Peter Sargent as new chief executive, as Jim Millen bec...
Follow the stocks
